I say a professional would never have remained short during that rise and would have covered. I say an amateur would not have the capital to withstand the losses of the last upward move. I say the chances that he was still short before today's move are slim and none. Finally, I say I have picked up bargains today in this wonderful stock. Long and strong.
I am delighted that in your business law course they covered fraudulent conveyance. Unfortunately, they did not teach you how to spell "dividend" instead of divident. More importantly, if you keep alleging a fraudulent conveyance in your attempt to drive the stock down (as if anyone listens to you) the General Counsel of FCX should send you a cease and desist letter along with a copy of his referral to the Securities and Exchange Commission. Alleging fraud is a serious matter, and outside of your First Amendment free speech rights. Shape up moron or face the consequences of your irresponsibility. Now repeat after me: "DIV-I-Dend."
I agree the board is dead. It is hard to believe that excellent earnings have not already been priced into the stock. There have been no rumors, but the price action screams takeover. Maybe they announce a deal.
Boy, was your analysis accurate. It is a little over a month after the Street Hack Job and ALKS has exploded upwards. Cramer is for entertainment, not investment advice.
Announce Date Dec 22, 2014
Ex-Dividend Date Jan 06, 2015
Payment Date Jan 15, 2015
Sailhappy, it is as easy as checking your brokerage account. It is not magic.Here is the information from Schwab. Have you considered not buying stocks and instead buying mutual funds?
They shouldnt regulate securities. They ought to regulate investors. Imagine, people allowed to buy and they don't know how to find out that KKR pays .46 on Jan 15, 2015 x dividend Jan 6. The original poster is right.
Time for you to take another beating, bigot. Your intellect is too weak to remain among the living. Prepare to be waste.
Up 4% on the day and you are proud that you shorted. I am a cheerleader though, I bought a second home with trading profits in this stock and now, I wish I had held on to every share I ever owned. This is a classic acquisition by a big Pharma, it is just a matter of time.
I hope to live long enough to see one of you phoneys admit that you got hammered on a poorly timed short. If you did cover, you got out one day before bankruptcy. Yeah, yeah, there is nothing wrong with swing trading a stock, but this one could take you to the poorhouse one day.
"may" face competition, "potential" competitors on and on of a parade of the horrible. Don't try so hard, investors in this company know that competition, particularly "potential" competition never goes away. Indeed, some of the potential competitors among big Pharma that you mention and others that you do not may be the future owners of GHDX after they tender for our shares at a premium. In any case there are advantages in being first to market, and new entrants to the market will be facing competition from GHDX, the established leader in the field. The defense rests.
It is also true that a few here have been buying the stock of this company since it was in single digits and have an average price that is still profitable. Management was clear about its strategy, and long term holders know that it has been successful for the most part in carrying it out. Short sellers, small float, and market conditions have had an foreseeable impact in the short term, but long term this company is a winner. Keep denying that, and maintaining your short positions. One day, it will bankrupt you.
Short sellers and day traders make a lot of noise on this board but the reality cannot be denied. This company is making ever deeper inroads into markets that are unserved and for which the moats that protect GHDX are huge. The performance of management in growing the company and pursuing its science is superb. Not managing to the stock price but to product developments and market share are going to produce a hell of a return in a few years. Short sellers have limited lifespan, this company has a future.